M&A Deal Summary

Gilde Healthcare Acquires EUROPIN

On February 10, 2022, private equity firm Gilde Healthcare acquired medical products company EUROPIN

Acquisition Highlights
  • This is Gilde Healthcare’s 11th transaction in the Medical Products sector.
  • This is Gilde Healthcare’s 1st transaction in Slovakia.

M&A Deal Summary
Date 2022-02-10
Target EUROPIN
Sector Medical Products
Buyer(s) Gilde Healthcare
Deal Type Buyout (LBO, MBO, MBI)

Target

EUROPIN

Trencianske Stankovce, Slovakia
EUROPIN develops and manufactures medical needles, such as pen cannulas and lancet needles for medical and pharmaceutical applications with a focus on injection systems for self-medication in the field of diabetes and hormone therapies. EUROPIN was founded in 1997 and is based in Trencianske Stankovce, Slovakia.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Gilde Healthcare

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1999
PE ASSETS 2.6B EUR
Size Large
Type Sector Focused
DESCRIPTION

Gilde Healthcare is a specialist private equity and venture investor focused on the healthcare sector. The Firm's buyout group targets majority investments throughout Europe (preference for Germany, the Netherlands, Belgium, Austria or Switzerland) and has a focus on healthcare providers, suppliers and service providers active in the healthcare market. The Firm's venture group looks to invest in early stage medtech, diagnostics, digital health and therapeutics companies throughout North America and Europe. Gilde Healthcare was established in 2001 and is headquartered in Utrecht, the Netherlands.

DEAL STATS #
Overall 43 of 47
Sector (Medical Products) 11 of 12
Type (Buyout (LBO, MBO, MBI)) 6 of 8
Country (Slovakia) 1 of 1
Year (2022) 1 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-12-14 Vesper Medical

Wayne, Pennsylvania, United States

Vesper Medical is a medical device company dedicated to the development of a novel venous stent for the treatment of a variety of venous diseases. The Company had achieved CE Mark and has initiated the VIVID trial in the US for FDA approval. Vesper Medical was founded in 2016 and is based in Wayne, Pennsylvania.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-02-16 SpliceBio

Barcelona, Spain

SpliceBio is a biotechnology company exploiting Protein Splicing to develop the next generation of gene therapies. SpliceBio is based in Barcelona, Spain.

Buy -
Mergr

Product

Company

Legal